Preconditioning the heart by brief coronary (CAO) or mesenteric artery occlusion (MAO) can protect against damage during subsequent prolonged CAO and reperfusion. The role of bradykinin (BK) in remote cardiac preconditioning by MAO is investigated by antagonizing the BK B(2) receptor [Hoechst 140 (HOE-140)] or simulating local BK release by mesenteric intra-arterial infusion. Anesthetized male Wistar rats (n = 6-8) were treated with HOE-140 or saline before starting the preconditioning protocol, CAO, MAO, or non-preconditioned control. Infarct size related to risk area [ratio of infarct area to area at risk (IA/AR)] was determined after 3 h of reperfus...
The present study was designed to investigate the effect of early and late administration of phenyle...
AbstractObjectives. To investigate the role of kinin in preconditioning against infarction, the pres...
Short non-lethal ischemic episodes administered to hearts prior to (ischemic preconditioning, IPC) o...
Objectives: Substantial release of bradykinin has been demonstrated to occur during short periods of...
Very few therapeutic modalities are beneficial in the treatment of acute myocardial infarction. Howe...
AbstractOBJECTIVESThe purpose of this study was to determine whether administration of bradykinin re...
Abstract. : Short episodes of ischemia (ischemic preconditioning) protect the heart against ventricu...
AbstractBackgroundIschemia/reperfusion (I/R) injury is a major contributory factor to cardiac dysfun...
OBJECTIVE: To examine whether endogenous bradykinin mediates the endothelium-dependent vasomotor dys...
Local and remote ischemic preconditioning (IPC) reduce ischemia-reperfusion (I/R) injury and preserv...
OBJECTIVE: Pharmacological post-conditioning (PC) by intermittent but not continuous administration ...
Myocardial bradykinin (BK) levels increase during ischemia. BK modulates cardiac efferent nerves and...
The aims of this study were to assess whether ischemic preconditioning (PC) induces bradykinin (Bk) ...
We previously reported that bradykinin (BK; 1–1000 nM) facil-itates norepinephrine (NE) release from...
Although recent investigations have disclosed that preconditioning limits myocardial infarct size by...
The present study was designed to investigate the effect of early and late administration of phenyle...
AbstractObjectives. To investigate the role of kinin in preconditioning against infarction, the pres...
Short non-lethal ischemic episodes administered to hearts prior to (ischemic preconditioning, IPC) o...
Objectives: Substantial release of bradykinin has been demonstrated to occur during short periods of...
Very few therapeutic modalities are beneficial in the treatment of acute myocardial infarction. Howe...
AbstractOBJECTIVESThe purpose of this study was to determine whether administration of bradykinin re...
Abstract. : Short episodes of ischemia (ischemic preconditioning) protect the heart against ventricu...
AbstractBackgroundIschemia/reperfusion (I/R) injury is a major contributory factor to cardiac dysfun...
OBJECTIVE: To examine whether endogenous bradykinin mediates the endothelium-dependent vasomotor dys...
Local and remote ischemic preconditioning (IPC) reduce ischemia-reperfusion (I/R) injury and preserv...
OBJECTIVE: Pharmacological post-conditioning (PC) by intermittent but not continuous administration ...
Myocardial bradykinin (BK) levels increase during ischemia. BK modulates cardiac efferent nerves and...
The aims of this study were to assess whether ischemic preconditioning (PC) induces bradykinin (Bk) ...
We previously reported that bradykinin (BK; 1–1000 nM) facil-itates norepinephrine (NE) release from...
Although recent investigations have disclosed that preconditioning limits myocardial infarct size by...
The present study was designed to investigate the effect of early and late administration of phenyle...
AbstractObjectives. To investigate the role of kinin in preconditioning against infarction, the pres...
Short non-lethal ischemic episodes administered to hearts prior to (ischemic preconditioning, IPC) o...